About this data
What it is
ClinicalTrials.gov is the US registry of clinical studies. Drug and device makers register their trials there and update the record as each study moves on. We list the studies that companies sponsor, and match the sponsor to a public company when the name lines up. The page opens on Phase 3 studies marked completed, the late-stage trials that come before a request for approval. Change View to see the changes of status we have noticed, or every recent update.
Who files it
The sponsor of the study, in its record on ClinicalTrials.gov. The registry is run by the US National Library of Medicine and does not check what sponsors report.
How current
We check the registry every day. Sponsors update records on their own schedule, from the same week to months later, so a change can appear in the registry well after it happened.
Terms
ClinicalTrials.govClinicalTrials.gov is the US government's registry of clinical studies, run by the National Library of Medicine. Sponsors register a study before it starts and update the record as it goes. The registry does not check what a sponsor reports.Phase 3The late stage of testing, usually with hundreds or thousands of people, to confirm that a treatment works and to find side effects. A study marked Phase 2/3 covers both stages.statusThe registry's own word for where a study stands: not yet recruiting, recruiting, active but not recruiting, completed, terminated (stopped early), withdrawn (never started), suspended, or unknown (the sponsor has not confirmed the record for a long time).completedThe sponsor has marked the study as finished. It says nothing about whether the treatment worked: results, if any, are reported separately and often later.status changesOur history of status changes starts the day we first stored each study, so a change made before that is not shown. The date is when we noticed the change, which can be later than when the sponsor made it.primary completionThe date the last participant is examined for the main question the study asks. The study can run on after it, for follow-up. Sponsors enter the date and revise it, and an estimated date can pass without an update.company matchWe match the sponsor's name to a public company automatically, and by hand for the large drugmakers. A subsidiary or a differently spelled name can be missed, so a study with no ticker does not mean the sponsor is private.
Worth knowing
A completed study is not a result: the registry says the study ended, not whether the treatment worked. Status changes start on the day we first stored each study, so earlier changes are not shown. Dates are the sponsor's own, and an estimated date can pass without an update. We match sponsors to companies automatically, with a hand-checked list for the large drugmakers, so a study with no ticker may still belong to a public company. This is information about studies, not a forecast of what they will show or of a stock's price.
Not to be confused with
FDA approvals and clearances: what the FDA decided, not what a sponsor reports about a study.

All of this comes from ClinicalTrials.gov, the US registry of clinical studies. We are not affiliated with it.

Studies updated per day, last 30 days

0200400600Oct 17 · All industry-sponsored studies: 0Oct 17 · Sponsor matched to a public company: 0Oct 17Oct 18 · All industry-sponsored studies: 0Oct 18 · Sponsor matched to a public company: 0Oct 19 · All industry-sponsored studies: 238Oct 19 · Sponsor matched to a public company: 79Oct 20 · All industry-sponsored studies: 278Oct 20 · Sponsor matched to a public company: 92Oct 21 · All industry-sponsored studies: 244Oct 21 · Sponsor matched to a public company: 78Oct 21Oct 22 · All industry-sponsored studies: 234Oct 22 · Sponsor matched to a public company: 67Oct 23 · All industry-sponsored studies: 259Oct 23 · Sponsor matched to a public company: 93Oct 24 · All industry-sponsored studies: 0Oct 24 · Sponsor matched to a public company: 0Oct 25 · All industry-sponsored studies: 0Oct 25 · Sponsor matched to a public company: 0Oct 25Oct 26 · All industry-sponsored studies: 253Oct 26 · Sponsor matched to a public company: 70Oct 27 · All industry-sponsored studies: 283Oct 27 · Sponsor matched to a public company: 102Oct 28 · All industry-sponsored studies: 287Oct 28 · Sponsor matched to a public company: 97Oct 29 · All industry-sponsored studies: 256Oct 29 · Sponsor matched to a public company: 88Oct 29Oct 30 · All industry-sponsored studies: 252Oct 30 · Sponsor matched to a public company: 103Oct 31 · All industry-sponsored studies: 0Oct 31 · Sponsor matched to a public company: 0Nov 1 · All industry-sponsored studies: 0Nov 1 · Sponsor matched to a public company: 0Nov 2 · All industry-sponsored studies: 305Nov 2 · Sponsor matched to a public company: 99Nov 2Nov 3 · All industry-sponsored studies: 478Nov 3 · Sponsor matched to a public company: 257Nov 4 · All industry-sponsored studies: 390Nov 4 · Sponsor matched to a public company: 184Nov 5 · All industry-sponsored studies: 356Nov 5 · Sponsor matched to a public company: 143Nov 6 · All industry-sponsored studies: 338Nov 6 · Sponsor matched to a public company: 135Nov 6Nov 7 · All industry-sponsored studies: 0Nov 7 · Sponsor matched to a public company: 0Nov 8 · All industry-sponsored studies: 0Nov 8 · Sponsor matched to a public company: 0Nov 9 · All industry-sponsored studies: 309Nov 9 · Sponsor matched to a public company: 101Nov 10 · All industry-sponsored studies: 347Nov 10 · Sponsor matched to a public company: 139Nov 10Nov 11 · All industry-sponsored studies: 0Nov 11 · Sponsor matched to a public company: 0Nov 12 · All industry-sponsored studies: 576Nov 12 · Sponsor matched to a public company: 214Nov 13 · All industry-sponsored studies: 329Nov 13 · Sponsor matched to a public company: 136Nov 14 · All industry-sponsored studies: 0Nov 14 · Sponsor matched to a public company: 0Nov 14Nov 15 · All industry-sponsored studies: 0Nov 15 · Sponsor matched to a public company: 0
0200400600Oct 17 · All industry-sponsored studies: 0Oct 17 · Sponsor matched to a public company: 0Oct 17Oct 18 · All industry-sponsored studies: 0Oct 18 · Sponsor matched to a public company: 0Oct 19 · All industry-sponsored studies: 238Oct 19 · Sponsor matched to a public company: 79Oct 20 · All industry-sponsored studies: 278Oct 20 · Sponsor matched to a public company: 92Oct 21 · All industry-sponsored studies: 244Oct 21 · Sponsor matched to a public company: 78Oct 21Oct 22 · All industry-sponsored studies: 234Oct 22 · Sponsor matched to a public company: 67Oct 23 · All industry-sponsored studies: 259Oct 23 · Sponsor matched to a public company: 93Oct 24 · All industry-sponsored studies: 0Oct 24 · Sponsor matched to a public company: 0Oct 25 · All industry-sponsored studies: 0Oct 25 · Sponsor matched to a public company: 0Oct 25Oct 26 · All industry-sponsored studies: 253Oct 26 · Sponsor matched to a public company: 70Oct 27 · All industry-sponsored studies: 283Oct 27 · Sponsor matched to a public company: 102Oct 28 · All industry-sponsored studies: 287Oct 28 · Sponsor matched to a public company: 97Oct 29 · All industry-sponsored studies: 256Oct 29 · Sponsor matched to a public company: 88Oct 29Oct 30 · All industry-sponsored studies: 252Oct 30 · Sponsor matched to a public company: 103Oct 31 · All industry-sponsored studies: 0Oct 31 · Sponsor matched to a public company: 0Nov 1 · All industry-sponsored studies: 0Nov 1 · Sponsor matched to a public company: 0Nov 2 · All industry-sponsored studies: 305Nov 2 · Sponsor matched to a public company: 99Nov 2Nov 3 · All industry-sponsored studies: 478Nov 3 · Sponsor matched to a public company: 257Nov 4 · All industry-sponsored studies: 390Nov 4 · Sponsor matched to a public company: 184Nov 5 · All industry-sponsored studies: 356Nov 5 · Sponsor matched to a public company: 143Nov 6 · All industry-sponsored studies: 338Nov 6 · Sponsor matched to a public company: 135Nov 6Nov 7 · All industry-sponsored studies: 0Nov 7 · Sponsor matched to a public company: 0Nov 8 · All industry-sponsored studies: 0Nov 8 · Sponsor matched to a public company: 0Nov 9 · All industry-sponsored studies: 309Nov 9 · Sponsor matched to a public company: 101Nov 10 · All industry-sponsored studies: 347Nov 10 · Sponsor matched to a public company: 139Nov 10Nov 11 · All industry-sponsored studies: 0Nov 11 · Sponsor matched to a public company: 0Nov 12 · All industry-sponsored studies: 576Nov 12 · Sponsor matched to a public company: 214Nov 13 · All industry-sponsored studies: 329Nov 13 · Sponsor matched to a public company: 136Nov 14 · All industry-sponsored studies: 0Nov 14 · Sponsor matched to a public company: 0Nov 14Nov 15 · All industry-sponsored studies: 0Nov 15 · Sponsor matched to a public company: 0

All industry-sponsored studies Sponsor matched to a public company

By the day the sponsor last updated the study's record. A study updated twice counts once, on its latest day.

Latest clinical trial updates

Reset

Showing: ticker SGHT · All recent updates

Studies by the date their record was last updated.

Latest clinical trial updates
UpdatedStudySponsorWe match the sponsor's name to a public company automatically, and by hand for the large drugmakers. A subsidiary or a differently spelled name can be missed, so a study with no ticker does not mean the sponsor is private.PhaseThe late stage of testing, usually with hundreds or thousands of people, to confirm that a treatment works and to find side effects. A study marked Phase 2/3 covers both stages.StatusThe registry's own word for where a study stands: not yet recruiting, recruiting, active but not recruiting, completed, terminated (stopped early), withdrawn (never started), suspended, or unknown (the sponsor has not confirmed the record for a long time).EnrolledPrimary completionThe date the last participant is examined for the main question the study asks. The study can run on after it, for follow-up. Sponsors enter the date and revise it, and an estimated date can pass without an update.Source
Nov 13, 2026TearCare MGX™ System With and Without Warming Hold
NCT07365735 · Meibomian Gland Dysfunction (Disorder)
localized heat therapy
SGHT
Sight Sciences, Inc.
Not applicableCompleted21May 19, 2026Registry ↗
Oct 19, 2026OMNI 3.1 Surgical System in Subjects With Primary Open-Angle Glaucoma
NCT06991270 · Primary Open Angle Glaucoma
OMNI 3.0 Surgical System
SGHT
Sight Sciences, Inc.
Not applicableActive, not recruiting25Dec 1, 2026Registry ↗
Jul 7, 2026A Study of the Helix Surgical System in Primary Open-Angle Glaucoma (POAG) and Cataract (HELIX)
NCT06948773 · Primary Open Angle Glaucoma, Cataract
Helix Surgical System
SGHT
Sight Sciences, Inc.
Not applicableActive, not recruiting25Sep 30, 2026Registry ↗
Nov 24, 2025Safety And Effectiveness Of The TearCare® System In The Treatment Of The Signs And Symptoms Of Dry…
NCT04795752 · Dry Eye, Meibomian Gland Dysfunction
TearCare System, Cyclosporine Ophthalmic 0.05% Ophthalmic E…
SGHT
Sight Sciences, Inc.
Not applicableCompleted345Sep 23, 2024Registry ↗
Nov 14, 2025Safety and Effectiveness of the Sight Sciences VISCO™360 Versus SLT in Primary Open Angle Glaucoma
NCT02928289 · Open-Angle Glaucoma
VISCO360 ab interno canaloplasty surgery, Selective Laser T…
SGHT
Sight Sciences, Inc.
Not applicableTerminated29Jan 17, 2019Registry ↗
Oct 28, 2025Pilot Study of TearCare System - Long-Term Extension
NCT03804502 · Dry Eye Syndromes
TearCare
SGHT
Sight Sciences, Inc.
Not applicableCompleted12May 21, 2019Registry ↗
Oct 27, 2025Study of OMNI Surgical System and iStent for Eyes With OAG (Trident)
NCT04658095 · Glaucoma, Open-Angle
Canaloplasty and trabeculotomy with the OMNI system., iSten…
SGHT
Sight Sciences, Inc.
Not applicableTerminated10Nov 18, 2022Registry ↗
Oct 15, 2025A Pilot Study of the TearCare System in Adults With Dry Eye Disease
NCT03006978 · Dry Eye
TearCare, Warm Compress
SGHT
Sight Sciences, Inc.
Not applicableCompleted24Feb 2017Registry ↗
Oct 1, 2025TearCare System to Treat Dry Eye Disease
NCT03857919 · Dry Eye, Meibomian Gland Dysfunction
TearCare, LipiFlow
SGHT
Sight Sciences, Inc.
Not applicableCompleted235Feb 17, 2020Registry ↗
Sep 29, 2025Randomized Study of the Safety and Effectiveness of the TearCare System for the Signs and Symptoms…
NCT03502447 · Dry Eye Syndromes
TearCare, Warm Compress and Lid Massage
SGHT
Sight Sciences, Inc.
Not applicableTerminated14Dec 4, 2018Registry ↗
Sep 11, 2025Study of the TearCare System in Dry Eye Disease
NCT03588624 · Dry Eye
TearCare
SGHT
Sight Sciences, Inc.
Not applicableCompleted29Oct 11, 2018Registry ↗
May 22, 2025An Observational Multicenter Clinical Study To Assess The Safety And Effectiveness Of The OMNI® Sur…
NCT04872348 · Glaucoma, Open-Angle
OMNI® Surgical System
SGHT
Sight Sciences, Inc.
—Completed28Nov 2, 2023Registry ↗
Jan 29, 2025A Clinical Trial Comparing the OMNI Surgical System to Standard Medical Treatment in Patients With…
NCT06407973 · Primary Open Angle Glaucoma
OMNI Surgical System, Latanoprost plus adjunctive glaucoma…
SGHT
Sight Sciences, Inc.
Phase 4Terminated2Jan 20, 2025Registry ↗
Jan 22, 2025A Clinical Study To Assess The Safety And Effectiveness Of The OMNI® Surgical System
NCT05044793 · Glaucoma, Open-Angle
OMNI® Surgical System
SGHT
Sight Sciences, Inc.
—Completed70Aug 21, 2023Registry ↗
Aug 14, 2024Study of OMNI System in OAG (GEMINI)
NCT03861169 · Open Angle Glaucoma
Transluminal viscoelastic delivery and trabeculotomy
SGHT
Sight Sciences, Inc.
Not applicableCompleted209May 4, 2021Registry ↗
Dec 1, 2022A Post-market Study Of Use Of The OMNI® Surgical System In Open Angle Glaucoma
NCT04616573 · Glaucoma, Open-Angle
OMNI® Surgical System, iStent inject
SGHT
Sight Sciences, Inc.
Not applicableTerminated1Jan 20, 2021Registry ↗
Jun 28, 2022A Prospective, Multicenter Study of the OMNI® Surgical System in Pseudophakic Eyes With Open Angle…
NCT04465630 · Glaucoma, Open-Angle
OMNI® Surgical System
SGHT
Sight Sciences, Inc.
Not applicableTerminated78Mar 2, 2021Registry ↗

17 items, most recent first (up to 50). Each row links to the study's page on ClinicalTrials.gov. Updated Nov 15, 2026, 8:46 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · FDA approvals and clearances